[Progress on a new form of treatment of lipoarteriosis].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D007294:Inositol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity; D012907:Smoking; D013312:Stress, Physiological
D000924:Anticholesteremic Agents; D009539:Nicotinic Acids; D007294:Inositol
Avance sobre una nueva forma de tratamiento de la liparteriosis.